S100 protein in the vertebrate peripheral nervous system consists of homo-or heterodimers of S100␣ and S100 proteins, the first predominating in neurons and the second in glial cells. Recently, however, occurrence of S100 protein in neurons has been reported. The expression of S100 protein by Schw
Different distributions of immunoreactive S100-α and S100-β protein expression in human breast cancer
✍ Scribed by Funahashi, Hiroomi; Koshikawa, Takashi; Ichihara, Shu; Ohike, Ekoh; Katoh, Kanehusa
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 625 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Background and Objectives: Although the localization of S100 protein in breast carcinoma has previously been studied, the immunohistochemical expression of the S100-␣ and - subunits has not been examined. Methods: Immunohistochemical staining for S100-␣ and S100- proteins was performed on 72 benign breast lesions and 72 infiltrating ductal carcinoma of the breast. Noncross-reactive anti-S100-␣ and anti-S100- antibodies purified by affinity chromatography were used in the studies. Results: More than 30% of the epithelial cells comprising all the benign lesions were either S100-␣ or S100- positive. In breast carcinoma cases, however, >30% of malignant cells were S100-␣ positive in 70/72 cases (97.2%), whereas the number of S100- positive cells exceeded 30% in only 3/72 cases (4.0%). Conclusions: Immunohistochemical staining for S100-␣ and S100- proteins may help to differentiate benign proliferative breast lesions from breast cancers in difficult cases.
📜 SIMILAR VOLUMES
Our aim was to compare the occurrence and prognostic significance over 14 -20 years of immunocytochemically detected S100A4 and other tumour variables in primary tumours from 349 patients with operable breast cancer. For a cut-off of 1% staining of the malignant cells, the antibody to S100A4 stains